These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21252656)

  • 1. Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.
    Bhatia R; Deeg HJ
    Curr Opin Hematol; 2011 Mar; 18(2):77-82. PubMed ID: 21252656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
    Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related myelodysplastic syndromes, or are they?
    Abou Zahr A; Kavi AM; Mukherjee S; Zeidan AM
    Blood Rev; 2017 May; 31(3):119-128. PubMed ID: 27923516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.
    Crisà E; Boggione P; Nicolosi M; Mahmoud AM; Al Essa W; Awikeh B; Aspesi A; Andorno A; Boldorini R; Dianzani I; Gaidano G; Patriarca A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.
    Nassereddine S; Nishihori T; Padron E; Mahfouz R; Bazarbachi A; Komrokji RS; Kharfan-Dabaja MA
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):7-13. PubMed ID: 27771290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.
    Mishra A; Anasetti C
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S49-52. PubMed ID: 27521324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
    Heuser M; Gabdoulline R; Löffeld P; Dobbernack V; Kreimeyer H; Pankratz M; Flintrop M; Liebich A; Klesse S; Panagiota V; Stadler M; Wichmann M; Shahswar R; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Geffers R; Schlegelberger B; Göhring G; Kreipe HH; Germing U; Ganser A; Kröger N; Koenecke C; Thol F
    Ann Hematol; 2017 Aug; 96(8):1361-1372. PubMed ID: 28612220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
    Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
    Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.
    Konuma T; Miyazaki Y; Uchida N; Ohashi K; Kondo T; Nakamae H; Takahashi S; Mori T; Ozawa Y; Kato C; Iwato K; Fukuda T; Ichinohe T; Atsuta Y; Ishiyama K;
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):75-80. PubMed ID: 27777139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes.
    Kobbe G; Schroeder T; Rautenberg C; Kaivers J; Gattermann N; Haas R; Germing U
    Expert Rev Hematol; 2019 Oct; 12(10):821-831. PubMed ID: 31322458
    [No Abstract]   [Full Text] [Related]  

  • 12. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
    Falconi G; Fabiani E; Criscuolo M; Fianchi L; Finelli C; Cerqui E; Pelosi E; Screnci M; Gurnari C; Zangrilli I; Postorino M; Laurenti L; Piciocchi A; Testa U; Lo-Coco F; Voso MT
    Leuk Res; 2019 Sep; 84():106191. PubMed ID: 31386932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric myelodysplastic syndromes.
    Niemeyer CM; Kratz CP; Hasle H
    Curr Treat Options Oncol; 2005 May; 6(3):209-14. PubMed ID: 15869732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the treatment of myelodysplastic syndromes].
    Gelsi-Boyer V; Vey N
    Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in hematopoietic cell transplantation in myelodysplastic syndrome.
    Copelan EA; Grunwald MR; Sanikommu SR; Hussain MJ; Avalos B
    Discov Med; 2017 Aug; 24(130):51-57. PubMed ID: 28950075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
    Lindsley RC; Saber W; Mar BG; Redd R; Wang T; Haagenson MD; Grauman PV; Hu ZH; Spellman SR; Lee SJ; Verneris MR; Hsu K; Fleischhauer K; Cutler C; Antin JH; Neuberg D; Ebert BL
    N Engl J Med; 2017 Feb; 376(6):536-547. PubMed ID: 28177873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB; Kadam NN
    Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial incidence of myelodysplastic syndromes].
    Wróbel T; Mazur G; Pyszel A; Biedroń M; Kuliczkowski K
    Wiad Lek; 2006; 59(3-4):285-8. PubMed ID: 16813282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.